1Nuredn P, Bihour C, Smith M, et al. Platelet activation and thrombosis: studies in patients with essential thrombocythemia[J]. Am J Hematol, 1996, 51: 79-84.
2Luisa-Gregorini J, Marl O, et al. Ticlopidine and aspirin pretreatment reduce coagulation and platelet activation during coronary dilation procedures [J]. JACC, 1997, 29: 13-20.
3Henn V, Slupsky JR, Grafe M, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells[J]. Nature, 1998, 391: 591-594.
4Biasucci LM, Luizzo G,Grillo RL, et al. Elevated Levels of Creactive protein at discharge in patients with unstable angina predict recurrent in-stability[J]. Circulation, 1999, 99: 855-860.
5Fragmin during instability in coronary artery disease (FRISC) study group. Low molecular weight heparin during instability in coronary artery disease[J]. Lancet, 1996,347:561.
7Hoffmcister HM ,Jur M, Wendel P,et al. Alteration of coagulation and fibrinolytic and kallikreinkinin system in acute and postacute phase in patients with unstable angina pectoris[J].Circulation, 1995,91 : 2520.
8Bacher P,Iqbal O,Lojewski B,et al. A simulated post angicplasty low molecular weight heparin schedule in a non-human primate mode[J]. Thromb Research, 1993,70(4) : 295- 306.
9Schafer AI. Low molecular weight heparin-an opportunity for home treament of venous thrombosis[J]. N Engl J Med, 1996,334:724.
10Fragmin during instability in coronary artery disease(FRISC) study group. Low molecular weight heparin during instability in coronary artery disease[J]. Lancet,1996,347:561.
